-
10-day decitabine versus conventional chemotherapy (“3+7”) followed by allografting in AML patients ≥ 60 years: Long-term follow-up results of the randomized phase III trial AML21 of the EORTC leukemia group, GIMEMA and german MDS Study group
Michael Lübbert, Pierre Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +29 more
2citations -
Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Jean‐Jacques Kiladjian, Alberto Álvarez‐Larrán, Konstanze Döhner
2citations -
Dynamics of Oligoclonal Hematopoiesis in Severe Aplastic Anemia Patients Undergoing Immunosuppressive Treatment: Longitudinal Somatic Mutation Analysis from the EBMT Race Trial
Riley Cook, Simona Iacobelli, Austin Gladston Kulasekararaj, Giorgio Napolitani, Sıla Gerlevik, Nogayhan Seymen, +18 more
2citations -
Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study2025 Blood article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
U. Herrmann, Matthias Felber, Austen J. J. Worth, Zehra Şule Haskoloğlu, Figen Doğu, Victor Anthony Lewis, +30 more
2citations -
Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
Rob Pieters, Hester A. de Groot‐Kruseman, Femke Verwer, Merian van Overveld, Edwin Sonneveld, Marta F. Fiocco, +10 more
2citations -
Human precursor labeling in situ reveals a conveyor belt differentiation trajectory and a 6-day neutrophil life span2026 Blood article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Erinke van Grinsven, Tamar Tak, Marwan Hassani, Selma van Staveren, Suzanne Bongers, Joris Bekkers, +9 more
2citations -
Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7
Lori Ann Leslie, Gerardo Musuraca, Pau Abrisqueta, Joshua Brody, Jacob Haaber Christensen, Alexander Fosså, +8 more
2citations -
A Meta-Analysis of Hypersensitivity to Pegylated Escherichia coli Asparaginase Used As First-Line Treatment in Contemporary Pediatric Acute Lymphoblastic Leukemia Protocols
Leiah J. Brigitha, Marta F. Fiocco, Rob Pieters, Birgitte Klug Albertsen, Gabriele Escherich, Elixabet López-López, +5 more
2citations -
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study2020 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +15 more
2citations -
Subcutaneous Daratumumab with Rapid Corticosteroid Tapering in Relapsed or Refractory Multiple Myeloma Patients: Part 3 Update of the Open-Label, Multicenter, Phase 1b Pavo Study
Hareth Nahi, Saad Z. Usmani, María‐Victoria Mateos, Niels W.C.J. van de Donk, Philippe Moreau, Albert Oriol, +8 more
2citations -
Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospective, Natural History Study
Emilie Vander Haar, Courtney Abshier Ware, Gwen Allen, Róisín Armstrong, Michael Bombara, David N. Dhanraj, +12 more
2citations -
Transplant Outcomes for Acute Myeloid Leukemia or Myelodysplastic Syndromes Secondary to Acquired Aplastic Anemia or Paroxysmal Nocturnal Hemoglobinuria: A Report from the EBMT Severe Aplastic Anemia Working Party
Pedro Henrique Prata, Dirk‐Jan Eikema, Brian Piepenbroek, Austin Gladston Kulasekararaj, Beatrice Drexler, Jennifer M.L. Tjon, +19 more
2citations -
Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study
Selim Corbacioglu, Jarl Mooyaart, Emmanuelle Polge, William Boreland, Jessica Lemaitre, Christophe Peczynski, +20 more
2citations -
Optimization of Targeted Lipid Nanoparticle for the Treatment of RUNX1::ETO Driven AML2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery Open access
L. Daniel Mata Casimiro, Manisha du Plessis, Dennis Unthan, Heyang Zhang, Matthias Barz, Raymond Michel Schiffelers, +1 more
2citations -
Pharmacodynamic Signatures and Correlatives of Response in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Talquetamab or Teclistamab Plus Daratumumab and Pomalidomide
Deeksha Vishwamitra, Sheri Skerget, Kalpana K. Bakshi, Lien Vandenberk, Weili Sun, Jaszianne A. Tolbert, +26 more
2citations -
Oral Iptacopan Monotherapy Leads to Long-Term Improvements in Patient (Pt)-Reported Health-Related Quality of Life (HRQoL) and Investigator-Assessed Signs and Symptoms of Paroxysmal Nocturnal Hemoglobinuria (PNH): 48-Week (Wk) Results from the Phase III APPLY-PNH and APPOINT-PNH Trials
Antonio Maria Risitano, Bing Han, Austin Gladston Kulasekararaj, Yasutaka Ueda, Phillip Scheinberg, Jaroslaw Pawel Maciejewski, +7 more
2citations